Primary study · included by 1 review

Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects.

Kitamura 2016 · Kitamura Masahiro, Akamatsu Motoki, Kawanami Masamitsu, et al. · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2016

Included by

Clinical efficacy of different biomaterials for the regenerative treatment of periodontal intrabony defects: a systematic review and Bayesian network meta-analysis.

Non-Cochrane · intervention · 2026 · cited as Kitamura 2016 · Table 1

The review does not say which of its outcomes this study informs.

1 including review in total.